Fine Mark National Bank & Trust Harrow Health, Inc. Transaction History
Fine Mark National Bank & Trust
- $2.7 Billion
- Q2 2024
A detailed history of Fine Mark National Bank & Trust transactions in Harrow Health, Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 22,730 shares of HROW stock, worth $1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,730
Previous 22,730
-0.0%
Holding current value
$1 Million
Previous $300,000
58.0%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
121Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$176 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$120 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$94.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$81.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$31.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.19B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...